Jan Vanbrabant new chairman of the board at ERBER AG

JVAThe ERBER AG Board, Holding Company of ERBER Group (BIOMIN, ROMER LABS, SANPHAR, BIO-FERM and EFB), announces that Jan Vanbrabant, PhD (50) will become chairman of the Executive Board of the Lower Austrian bio-technological company on 1 April, 2017.

Jan Vanbrabant has been working for ERBER Group since 2009 and in his function as Managing Director BIOMIN Asia Pacific significantly contributed to the development and the success of this region. Since October 2016, Jan Vanbrabant has been Director of Executive Board and in this position he was responsible for the processes for the departments of Procurement & Production, Sales & Marketing as well as Infrastructure of the entire ERBER Group.

After his PhD studies in Bio-chemistry/Microbiology at the University of Ghent (Belgium), he completed a bachelor’s degree in Economics and an Executive MBA in Marketing. His professional career has always been an international one. He has been an executive in pharmaceutical, as well as agricultural and biotechnological companies for more than 20 years.

In his new function as chairman of the Executive Board, Jan Vanbrabant will be responsible for ERBER Group’s future management and organization strategy worldwide.

Capture: Jan Vabrabant, PhD, Chairman of the Executive Board, ERBER AG

Close

erber-group.net uses cookies. By continuing to browse the site you are agreeing to our use of cookies. More information Accept cookies